Iontophoretic transdermal delivery and control of adverse side-e

Details Iontophoretic transdermal delivery and control of adverse side-e Iontophoretic transdermal delivery and control of adverse side-e

1997-01-29

2000-01-25

Bockelman, Mark

Surgery

Means for introducing or removing material from body for...

Infrared, visible light, ultraviolet, x-ray or electrical...

604501, A61N 130

Patent

active

060186798

ABSTRACT:
A method is disclosed for iontophoretically removing any compound that is capable of causing skin irritation or other harmful effects. More specifically, a bipolar iontophoretic transdermal delivery method is disclosed that includes a reversal phase for controlling the iontophoretic transdermal delivery of pharmaceutical compounds while reducing or eliminating skin irritation and terminating the pharmacological or toxicological effects in skin of drugs/cosmetics/active ingredients which form a drug depot in the skin after passive or iontophoretic application.

REFERENCES:
patent: 4141359 (1979-02-01), Jacobsen et al.
patent: 4301794 (1981-11-01), Tapper
patent: 4340047 (1982-07-01), Tapper et al.
patent: 4383529 (1983-05-01), Webster
patent: 4406658 (1983-09-01), Lattin et al.
patent: 4416274 (1983-11-01), Jacobsen et al.
patent: 4744787 (1988-05-01), Phipps et al.
patent: 4747819 (1988-05-01), Phipps et al.
patent: 4752285 (1988-06-01), Petelenz et al.
patent: 4764164 (1988-08-01), Sasaki
patent: 4915685 (1990-04-01), Petelenz et al.
patent: 5006108 (1991-04-01), LaPrade
patent: 5069908 (1991-12-01), Henley
patent: 5087242 (1992-02-01), Petelenz et al.
patent: 5133972 (1992-07-01), Ferrini et al.
patent: 5135477 (1992-08-01), Untereker et al.
patent: 5224927 (1993-07-01), Tapper
patent: 5236412 (1993-08-01), Lloyd et al.
patent: 5279543 (1994-01-01), Glikfeld et al.
patent: 5281287 (1994-01-01), Lloyd et al.
patent: 5286252 (1994-02-01), Tuttle et al.
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5320597 (1994-06-01), Sage, Jr. et al.
patent: 5328455 (1994-07-01), Lloyd et al.
patent: 5374241 (1994-12-01), Lloyd et al.
patent: 5415628 (1995-05-01), Untereker et al.
patent: 5582586 (1996-12-01), Tachibana et al.
patent: 5730715 (1998-03-01), Sage, Jr. et al.
Wong, Drugs Pharm. Sci. (1994), 62, 219-46, (1994).
Singh et al., Critical Reviews in Therapeutic Drug Carrier Systems, 11 (2 & 3): 161-213 (1994).
Kasting and Keister, J. Membrance Sci., 35, 137-159, (1988).

Affiliated with

Also associated with

Rating

Iontophoretic transdermal delivery and control of adverse side-e does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Iontophoretic transdermal delivery and control of adverse side-e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iontophoretic transdermal delivery and control of adverse side-e will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2322795